De­struc­tion of doc­u­ments, in­suf­fi­cient da­ta lead FDA to re­ject hep B vac­cine up­date

Dy­navax’s he­pati­tis B vac­cine was re­ject­ed for a la­bel ex­pan­sion in the US af­ter pa­tient da­ta was de­stroyed by a third-par­ty clin­i­cal tri­al site op­er­a­tor …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.